Поиск | Webyourself Social Media Platform

Ojas123 Sona добавлена новая статья Health
2024-12-03 16:00:49 -

Adoption of Advanced Technologies to Bolster Global Biosimilars Market
The Global Biosimilars Market was valued at USD 29.51 billion in 2023 and is projected to reach USD 127.92 billion by 2032, growing at a compound annual growth rate (CAGR) of 17.7% over the forecast period from 2024 to 2032. The market's expansion is driven by increasing adoption of biosimilars due to their cost-effectiveness, rising prevalence of chronic...

0 Комментарии 0 Поделились 88 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Bhavana Raja добавлена новая статья Health
2024-03-12 10:01:13 -

Antidiabetic Biosimilars Market Future Prospects and Forecast To 2030
The report "Antidiabetic Biosimilars Market by Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, ?-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others),by Disease Type (Type-I Diabetes, Type-II Diabetes), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region - Global Forecasts to...

0 Комментарии 0 Поделились 954 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Bhavana Raja добавлена новая статья Health
2023-09-04 10:07:08 -

Antidiabetic Biosimilars Market Trends and Segments Forecast To 2029
The global antidiabetic biosimilars market size was valued at x million in 2022 and is poised to grow at a significant CAGR of x% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....

0 Комментарии 0 Поделились 1574 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rohit Harne добавлена новая статья Health
2024-11-06 13:06:59 -

Asia Pacific Biosimilars Market: Rapid Market Growth Fueled by Increased Healthcare Access and Investment Forecast 2032
North America The North America Biosimilars Market is experiencing significant growth, primarily driven by the increasing demand for affordable biologic therapies and the rising adoption of biosimilars. The United States, with its large healthcare sector, represents the largest market in the region. Key factors contributing to the growth of the biosimilars market in North America...

0 Комментарии 0 Поделились 171 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rohit Harne добавлена новая статья Health
2024-11-04 12:21:08 -

Asia Pacific Oncology Biosimilars Market Trends and Regional Forecast 2032
North America The North America Oncology Biosimilars Market is expanding rapidly, largely driven by the increasing prevalence of cancer and the high cost of biologic treatments. The United States dominates this market with extensive biosimilar approvals by the FDA, a robust healthcare infrastructure, and initiatives to reduce healthcare costs. Canada is also experiencing growth due to...

0 Комментарии 0 Поделились 170 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Ashwini Bakhade добавлена новая статья Другое
2023-11-16 12:11:44 -

Automation Set To Accelerate Growth Of The Global Biosimilars Market
The global Biosimilars Market is estimated to be valued at US$ 29.4 Bn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Biosimilars are biologics that are highly similar to an approved biological drug known as the reference biologic product. Biosimilars offer advantages...

0 Комментарии 0 Поделились 1649 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Poojacmi Salve добавлена новая статья Другое
2023-07-12 12:00:03 -

Advancing Patient Care: The Impact of Biologics & Biosimilars
Biologics and Biosimilars are revolutionizing patient care across various medical fields. These innovative therapies have a significant impact on disease management, treatment outcomes, and overall quality of life for patients. Biologics, derived from living organisms, and their biosimilar counterparts are changing the way we approach conditions such as cancer, autoimmune diseases, and chronic...

0 Комментарии 0 Поделились 4986 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!

Расширенные страницы